Top

Published in:

01-10-2008 | Case Report

Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient

Authors: Yoji Moriyama, Yuzuru Minamidate, Mitsuru Yasuda, Hidetoshi Ehara, Mina Kikuchi, Tomohiro Tsuchiya, Takashi Deguchi, Hisashi Tsurumi

Published in: Urolithiasis | Issue 5/2008

Abstract

A 51-year-old HIV-positive man treated with atazanavir for 9 months presented with anuria following right flank pain. Laboratory examination indicated renal insufficiency, and abdominopelvic computed tomography scanning showed bilateral hydroureteronephrosis, but no stones were visualized. Endoscopic procedures were performed to investigate the causes of ureteral obstruction and, if possible, to insert Double-J stents in the ureters. A yellowish stone composed of pure atazanavir was found at the right ureteral orifice, and retrograde pyelography revealed a filling defect in the left ureter found to be caused by an atazanavir stone. The patient’s renal function recovered after removal of these stones.

Blake SP, McNicholas MM, Raptopoulous V (1998) Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy. AJR Am J Roentgenol 171:717–720PubMed

Chang HR, Pella PM (2006) Atazanavir urolithiasis. N Engl J Med 355:2158–2159. doi:10.1056/NEJMc061892 PubMedCrossRef

Pacanowski J, Poirier JM, Petit I, Meynard JL, Girard PM (2006) Atazanavir urinary stones in an HIV-infected patient. AIDS 20:2131. doi:10.1097/01.aids.0000247571.88256.90 PubMedCrossRef

Anderson PL, Lichtenstein KA, Gerig NE, Kiser JJ, Bushman LR (2007) Atazanavir-containing renal calculi in an HIV-infected patient. AIDS 12:1060–1062CrossRef

Couzigou C, Daudon M, Meynard JL et al (2007) Urolithiasis in HIV-positive patients treated with atazanavir. Clin Infect Dis 45:e105–e108. doi:10.1086/521930 PubMedCrossRef

Chan-Tack KM, Truffa MM, Struble KA, Birnkrant DB (2007) Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration’s Adverse Event Reporting System. AIDS 21:1215–1218. doi:10.1097/QAD.0b013e32813aee35 PubMedCrossRef

Brewster UC, Perazella MA (2004) Acute interstitial nephritis associated with atazanavir, a new protease inhibitor. Am J Kidney Dis 44:e81–e84. doi:10.1016/S0272-6386(04)01093-5 PubMedCrossRef

Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF (1997) Protease inhibitor-induced urolithiasis. Urology 50:508–511. doi:10.1016/S0090-4295(97)00401-9 PubMedCrossRef

Princeton NJ (2006) Rayataz product information. Bristol-Myers Squibb Co, Princeton

Title: Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient
Authors: Yoji Moriyama
Yuzuru Minamidate
Mitsuru Yasuda
Hidetoshi Ehara
Mina Kikuchi
Tomohiro Tsuchiya
Takashi Deguchi
Hisashi Tsurumi
Publication date: 01-10-2008
Publisher: Springer-Verlag
Published in: Urolithiasis / Issue 5/2008
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-008-0147-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2008

Nonstented versus routine stented ureteroscopic holmium laser lithotripsy: a prospective randomized trial

Unexpected complication: renal parenchymal perforation with double-J ureteral stent

Growth inhibition of Struvite crystals in the presence of juice of Citrus medica Linn.

In vitro simulation of stent fracture mechanisms in ureteric nitinol wire stents

X-ray diffraction analysis of urinary calculi: need for heat treatment

Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis